Article
Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
Cancer - 15 Aug 1992
Ohta T, Kikuchi H, Ogata H, Iwata K, Yoshida K, Katayama K, Watanabe H
Abstract excerpt
BACKGROUND: The efficiency of anti-CD3 antibody (OKT3) for adoptive immunotherapy using lymphokine-activated killer (LAK) cells generated from tumor-infiltrating lymphocytes (TIL), regional lymph node lymphocytes (RLNL), and peripheral blood lymphocytes (PBL) was investigated. METHODS: TIL, RLNL,...
Topics
- Aged
- Aged, 80 and over
- Antigens, Differentiation, T-Lymphocyte
- CD3 Complex
- Cell Division
- Cytotoxicity, Immunologic
- Female
- Gastrointestinal Neoplasms
- Humans
- Immunotherapy, Adoptive
- Interleukin-2
- Killer Cells, Lymphokine-Activated
- Killer Cells, Natural
- Lymph Nodes
- Lymphocytes
- Lymphocytes, Tumor-Infiltrating
- Male
- Middle Aged